Skip to content

Effect of test supplement on postprandial serum uric acid: A double blinded, placebo controlled, and cross over study

Effect of test supplement on postprandial serum uric acid: A double blinded, placebo controlled, and cross over study - Effect of test supplement on postprandial serum uric acid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033270
Enrollment
48
Registered
2018-07-12
Start date
2018-07-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male adults

Interventions

Sponsors

TTC Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Subjects aged from 20 to 65 years old 2. Subjects whose fasting serum uric acid level is between 5.0 mg/dL and 7.0 mg/dL at the screening examination.

Exclusion criteria

Exclusion criteria: 1. Subjects who usually take some medicine, foods for specified health uses, foods with function claims, health foods, or cosmetics including active ingredients 2. Subjects who have been taking foods affecting the study results once a week or more 3. Subjects who have gout in the past or are currently receiving treatment for hyperuricemia or gout (including exercise therapy, dietary guidance) 4. Subjects who are under treatment or have history of diseases (urinary stone, kidney stone, rheumatoid arthritis) which may influence the outcome of the study 5. Subjects who routinely use analgesics (non-steroidal analgesics, steroidal analgesics, etc.). 6.Subjects who habitually do intense exercise such as marathon 7. Subjects who cannot carry out the procedures of various inspections to be carried out during the research as specified 8. Subjects who have diseases requiring continuous medication, or serious medical history who needed medication therapy 9. Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) 10. Subjects with allergies to the test food in the study 11. Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on screening examination 12. Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study 13. Subjects who are judges as unsuitable for the study based on the results of lifestyle questionnaire 14. Subjects who are judged as unsuitable for the study by the investigator for other reason

Design outcomes

Primary

MeasureTime frame
Postprandial serum uric acid AUC

Secondary

MeasureTime frame
Postprandial serum uric acid levels, urinary excretion of uric acid, uric acid clearance, creatinine clearance, ratio of uric acid clearance to creatinine clearance

Countries

Japan

Contacts

Public ContactShingo Yamamichi

TTC Co., Ltd. Clinical Research Planning Department

s.yamamichi@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026